Clinical Trial Update: Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two doses of NT-201 to placebo for chronic troublesome sialorrhea in neurological conditions has completed. Results were posted in Febru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Sialorrhea
• Stroke
• Traumatic Brain Injury

Drugs mentioned

• NT 201

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Chronic Troublesome Sialorrhea, Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-02-15